SMN2
SMN2 (survival of motor neuron 2, centromeric; also BCD541, SMNC, GEMIN1 and TDRD16B) encodes the survival motor neuron protein, a core component of the SMN complex. This complex catalyses the assembly of small nuclear ribonucleoproteins and so supports the splicing of cellular pre-mRNAs. Browse Assay Genie's current range of SMN2 research reagents below, or read on for the biology behind the target.
The SMN complex catalyses the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Most spliceosomal snRNPs share a set of Sm proteins (SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG) that form a heptameric ring on the Sm site of the small nuclear RNA. In the cytosol, five of these Sm proteins are held in an inactive 6S pICln-Sm complex by the chaperone CLNS1A. The SMN complex accepts the trapped Sm proteins from CLNS1A, with SMN acting as a structural backbone and, together with GEMIN2, gathering the Sm subunits. Binding of snRNA triggers release of the SMN complex, allowing SNRPD3 and SNRPB to join and complete the core snRNP.
Beyond snRNP assembly, the SMN protein helps ensure correct splicing of U12 intron-containing genes, which may be important for the development of motor and proprioceptive neurons. It is also required for resolving RNA-DNA hybrids formed by RNA polymerase II in R-loops at transcription terminal regions, and may play a role in small nucleolar ribonucleoprotein metabolism. The protein localises to the cytoplasm and to nuclear gems, which lie near Cajal bodies, and is also found in neuron projections, axons and the sarcomere Z line. It forms complexes with proteins such as SIP1 and GEMIN4 and interacts with hnRNP U. The SMN2 gene belongs to the SMN family and is classed among Tudor domain containing proteins.
The SMN2 gene is part of a 500 kb inverted duplication on chromosome 5q13, a region prone to rearrangements and deletions. The centromeric SMN2 and telomeric SMN1 copies are nearly identical and encode the same protein. Mutations in the telomeric copy are associated with spinal muscular atrophy, whereas mutations in SMN2 do not lead to disease, though it may act as a modifier. The critical difference is a single nucleotide in exon 7, thought to be an exon splice enhancer. Four transcript variants encoding distinct isoforms have been described.
The SMN complex assembles Sm proteins onto small nuclear RNA to form core snRNPs, making SMN2 a focus for studies of spliceosome building.
SMN2 is the centromeric copy of SMN1 and may modify disease caused by mutations in the telomeric copy.
SMN helps ensure correct splicing of U12 intron-containing genes, which may be important for motor and proprioceptive neuron development.
SMN is required for resolving RNA-DNA hybrids created by RNA polymerase II, an important step in proper transcription termination.
SMN2 encodes the survival motor neuron protein, part of the SMN complex that catalyses snRNP assembly for pre-mRNA splicing. It also supports U12 intron splicing, helps resolve RNA-DNA hybrids in R-loops during transcription termination, and may contribute to snoRNP metabolism.
SMN2 is also known as BCD541, SMNC, GEMIN1 and TDRD16B. It is the centromeric copy of the gene; the telomeric copy is SMN1. Both encode the same protein and differ critically by a single nucleotide in exon 7, thought to be an exon splice enhancer.
Mutations in the telomeric copy, SMN1, are associated with spinal muscular atrophy. Mutations in SMN2, the centromeric copy, do not lead to disease, but the gene may act as a modifier of disease caused by SMN1 mutation. Gene conversion events may alter copy numbers of each.
The telomeric SMN1 copy and related snRNP-biogenesis targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16637; product specifications from Assay Genie datasheets.